Exploring Unmet Needs in Cancer Screening and the Value of Multi-Cancer Early-Detection Testing

Author(s)

Moderator: Anuraag Kansal, PhD, GRAIL, Inc, Piedmont, CA, USA
Speakers: J. Jaime Caro, MDCM, FRCPC, FACP, Evidera, Lincoln, MA, USA; Maarten IJzerman, PhD, Erasmus University, Rotterdam, Netherlands; Laura Housman, MPH, MBA, Avalere, Washington, DC, USA

Cancer remains the second-leading cause of death in the United States, striking about 1 in 3 women and 1 in 2 men in their lifetimes. Today, screening tests in the US are recommended for 5 cancers, but approximately 80% of cancer deaths come from cancers that have no recommended screening guidelines.

Recommended single cancer screening tests save lives, but this technology still only exists for a select number of cancer types. Instead of looking for cancer one-at-a-time, organ-by-organ, multi-cancer early detection technology has the ability to screen individuals for multiple cancers in a cost-effective manner. Adding these new technologies to single-cancer screening has the potential to change the cancer landscape and improve patient outcomes by helping to identify cancers at earlier, more treatable stages on a population scale.

Sponsor: GRAIL, Inc

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Code

238

Topic

Medical Technologies

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×